Literature DB >> 34097750

Lymph node metastases in breast cancer: investigating associations with tumor characteristics, molecular subtypes, and polygenic risk score using a continuous growth model.

Gabriel Isheden1, Felix Grassmann1,2, Kamila Czene1, Keith Humphreys1.   

Abstract

We investigate the association between rate of breast cancer lymph node spread and grade, estrogen receptor status, progesteron receptor status, decision tree derived PAM50 molecular subtype, and a polygenic risk score, using data on 10950 women included from two different data sources. Lymph node spread was analyzed using a novel continuous tumor progression model that adjusts for tumor volume in a biologically motivated way and that incorporates covariates of interest. Grade 2 and 3 tumors, respectively, were associated with 1.63 and 2.17 times faster rates of lymph node spread than grade 1 tumors (p<10-16). ER/PR negative breast cancer was associated with a 1.25/1.19 times faster spread than ER/PR positive breast cancer, respectively (p=0.0011 and p=0.0012). Among the molecular subtypes luminal A, luminal B, Her2-enriched, and basal-like, Her2-enriched breast cancer was associated with 1.53 times faster spread than luminal A cancer (p=0.00072). Polygenic risk score was not associated with the rate of lymph node spread. Continuous growth models are useful for quantifying associations between lymph node spread and tumor characteristics. These may be useful for building realistic progression models for microsimulation studies used to design individualized screening programs. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  Breast cancer; continuous growth model; lymph node metastases; molecular subtype; polygenic risk score

Year:  2021        PMID: 34097750     DOI: 10.1002/ijc.33704

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis.

Authors:  Mengzhen Yuan; Jun Zhang; Yuxin He; Guangming Yi; Liwen Rong; Liangjian Zheng; Tingting Zhan; Congming Zhou
Journal:  Arch Gynecol Obstet       Date:  2022-03-14       Impact factor: 2.493

2.  A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.

Authors:  Yuhan Yue; Junqing Liang; Yuruo Wu; Weibing Tong; Dan Li; Xuchen Cao; Xin Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.